Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical Cancer

NCT00782041 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

11

Enrollment

INDUSTRY

Sponsor class

Stopped protocol violation

Conditions

Uterine Neoplasms

Interventions

DRUG: Oxaliplatin
DRUG: 5-FluoroUracil
DRUG: Folinic acid

Sponsor

Sanofi